-
Something wrong with this record ?
Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors
A. Sabt, S. Kitsos, MS. Ebaid, V. Furlan, PD. Pantiora, M. Tsolka, EB. Elkaeed, MF. Hamissa, N. Angelis, OE. Tsitsilonis, AC. Papageorgiou, U. Bren, NE. Labrou
Language English Country United States
Document type Journal Article
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
Public Library of Science (PLoS)
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2006-12-01
Open Access Digital Library
from 2006-10-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-01-01
Medline Complete (EBSCOhost)
from 2008-01-01
Nursing & Allied Health Database (ProQuest)
from 2006-12-01
Health & Medicine (ProQuest)
from 2006-12-01
Public Health Database (ProQuest)
from 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- Chalcone chemistry pharmacology MeSH
- Chalcones chemistry pharmacology MeSH
- Glutathione S-Transferase pi * antagonists & inhibitors metabolism MeSH
- Enzyme Inhibitors pharmacology chemistry MeSH
- Coumarins * chemistry pharmacology MeSH
- Humans MeSH
- MCF-7 Cells MeSH
- Cell Line, Tumor MeSH
- Antineoplastic Agents pharmacology chemistry MeSH
- Molecular Docking Simulation * MeSH
- Sulfonamides * chemistry pharmacology MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Multidrug resistance (MDR) mechanisms in cancer cells are greatly influenced by glutathione transferase P1-1 (hGSTP1-1). The use of synthetic or natural compounds as hGSTP1-1 inhibitors is considered an effective approach to overcome MDR. Nine compounds consisting of coumarin-6-sulfonamide linked to chalcone derivatives were synthesized and evaluated for their ability to inhibit hGSTP1-1. Among the synthetic derivatives, compounds 5g, 5f, and 5a displayed the most potent inhibitory effect, with IC50 values of 12.2 ± 0.5 μΜ, 12.7 ± 0.7 and 16.3 ± 0.6, respectively. Kinetic inhibition analysis of the most potent molecule, 5g, showed that it behaves as a mixed-type inhibitor of the target enzyme. An in vitro cytotoxicity assessment of 5a, 5f, and 5g against the human prostate cancer cell lines DU-145 and PC3, as well as the breast cancer cell line MCF-7, demonstrated that compound 5g exhibited the most pronounced cytotoxic effect on all tested cell lines. Molecular docking studies were performed to predict the structural and molecular determinants of 5g, 5f, and 5a binding to hGSTP1-1. In agreement with the experimental data, the results revealed that 5g exhibited the lowest docking score among the three studied inhibitors as a consequence of shape complementarity, governed by van der Waals, hydrogen bonds and a π-π stacking interaction. These findings suggest that coumarin-chalcone hybrids offer new perspectives for the development of safe and efficient natural product-based sensitizers that can target hGSTP1-1 for anticancer purposes.
Department of Chemistry College of Science Northern Border University Arar Saudi Arabia
Department of Pharmaceutical Sciences College of Pharmacy AlMaarefa University Diriyah Saudi Arabia
Faculty of Chemistry and Chemical Engineering University of Maribor Maribor Slovenia
Institute of Environmental Protection and Sensors Maribor Slovenia
Institute of Organic Chemistry and Biochemistry Academy of Sciences Prague Czech Republic
Turku Bioscience Centre University of Turku and Åbo Akademi University Turku Finland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24019337
- 003
- CZ-PrNML
- 005
- 20241024111446.0
- 007
- ta
- 008
- 241015s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0306124 $2 doi
- 035 __
- $a (PubMed)39141629
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sabt, Ahmed $u Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Center, Dokki, Cairo, Egypt $1 https://orcid.org/0000000169760196
- 245 10
- $a Novel coumarin-6-sulfonamide-chalcone hybrids as glutathione transferase P1-1 inhibitors / $c A. Sabt, S. Kitsos, MS. Ebaid, V. Furlan, PD. Pantiora, M. Tsolka, EB. Elkaeed, MF. Hamissa, N. Angelis, OE. Tsitsilonis, AC. Papageorgiou, U. Bren, NE. Labrou
- 520 9_
- $a Multidrug resistance (MDR) mechanisms in cancer cells are greatly influenced by glutathione transferase P1-1 (hGSTP1-1). The use of synthetic or natural compounds as hGSTP1-1 inhibitors is considered an effective approach to overcome MDR. Nine compounds consisting of coumarin-6-sulfonamide linked to chalcone derivatives were synthesized and evaluated for their ability to inhibit hGSTP1-1. Among the synthetic derivatives, compounds 5g, 5f, and 5a displayed the most potent inhibitory effect, with IC50 values of 12.2 ± 0.5 μΜ, 12.7 ± 0.7 and 16.3 ± 0.6, respectively. Kinetic inhibition analysis of the most potent molecule, 5g, showed that it behaves as a mixed-type inhibitor of the target enzyme. An in vitro cytotoxicity assessment of 5a, 5f, and 5g against the human prostate cancer cell lines DU-145 and PC3, as well as the breast cancer cell line MCF-7, demonstrated that compound 5g exhibited the most pronounced cytotoxic effect on all tested cell lines. Molecular docking studies were performed to predict the structural and molecular determinants of 5g, 5f, and 5a binding to hGSTP1-1. In agreement with the experimental data, the results revealed that 5g exhibited the lowest docking score among the three studied inhibitors as a consequence of shape complementarity, governed by van der Waals, hydrogen bonds and a π-π stacking interaction. These findings suggest that coumarin-chalcone hybrids offer new perspectives for the development of safe and efficient natural product-based sensitizers that can target hGSTP1-1 for anticancer purposes.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a kumariny $x chemie $x farmakologie $7 D003374
- 650 12
- $a simulace molekulového dockingu $7 D062105
- 650 12
- $a glutathion-S-transferasa fí $x antagonisté a inhibitory $x metabolismus $7 D051549
- 650 12
- $a sulfonamidy $x chemie $x farmakologie $7 D013449
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a chalkon $x chemie $x farmakologie $7 D002599
- 650 _2
- $a protinádorové látky $x farmakologie $x chemie $7 D000970
- 650 _2
- $a chalkonoidy $x chemie $x farmakologie $7 D047188
- 650 _2
- $a inhibitory enzymů $x farmakologie $x chemie $7 D004791
- 650 _2
- $a MFC-7 buňky $7 D061986
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kitsos, Stefanos $u Laboratory of Enzyme Technology, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, Athens, Greece
- 700 1_
- $a Ebaid, Manal S $u Department of Chemistry, College of Science, Northern Border University, Arar, Saudi Arabia
- 700 1_
- $a Furlan, Veronika $u Faculty of Chemistry and Chemical Engineering, University of Maribor, Maribor, Slovenia
- 700 1_
- $a Pantiora, Panagiota D $u Laboratory of Enzyme Technology, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, Athens, Greece
- 700 1_
- $a Tsolka, Magdalini $u Laboratory of Enzyme Technology, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, Athens, Greece
- 700 1_
- $a Elkaeed, Eslam B $u Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Diriyah, Saudi Arabia
- 700 1_
- $a Hamissa, Mohamed Farouk $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Angelis, Nikolaos $u Section of Animal and Human Physiology, Department of Biology, National and Kapodistrian University of Athens (NKUA), Athens, Greece
- 700 1_
- $a Tsitsilonis, Ourania E $u Section of Animal and Human Physiology, Department of Biology, National and Kapodistrian University of Athens (NKUA), Athens, Greece
- 700 1_
- $a Papageorgiou, Anastassios C $u Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland
- 700 1_
- $a Bren, Urban $u Faculty of Chemistry and Chemical Engineering, University of Maribor, Maribor, Slovenia $u Faculty of Mathematics, Natural Sciences and Information Technologies, University of Primorska, Koper, Slovenia $u Institute of Environmental Protection and Sensors, Maribor, Slovenia
- 700 1_
- $a Labrou, Nikolaos E $u Laboratory of Enzyme Technology, Department of Biotechnology, School of Applied Biology and Biotechnology, Agricultural University of Athens, Athens, Greece
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 19, č. 8 (2024), s. e0306124
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39141629 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111439 $b ABA008
- 999 __
- $a ok $b bmc $g 2201902 $s 1231310
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 19 $c 8 $d e0306124 $e 20240814 $i 1932-6203 $m PloS one $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20241015